Northern Trust
HTGM

Northern Trust’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Northern Trust’s Portfolio HTGM Stock Details HTGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-512
Closed -$30K – 4431
2020
Q3 		$30K Buy
512
+34
+7% +$3.04K ﹤0.01% 4163
2020
Q2 		$62K Buy
478
+26
+6% +$2.3K ﹤0.01% 4019
2020
Q1 		$26K Hold
452
– – ﹤0.01% 4057
2019
Q4 		$57K Buy
452
+151
+50% +$20.4K ﹤0.01% 4033
2019
Q3 		$36K Hold
301
– – ﹤0.01% 4091
2019
Q2 		$90K Hold
301
– – ﹤0.01% 3991
2019
Q1 		$135K Hold
301
– – ﹤0.01% 3857
2018
Q4 		$138K Hold
301
– – ﹤0.01% 3860
2018
Q3 		$274K Sell
301
-6
-2% -$3.96K ﹤0.01% 3785
2018
Q2 		$180K Buy
307
+17
+6% +$11.1K ﹤0.01% 3888
2018
Q1 		$189K Buy
+290
New +$218K ﹤0.01% 3844

Other funds holding HTGM

CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return
SC
Samjo Capital New York $254M AUM 36.81% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $46.5B AUM 20.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return